|
Volumn 150, Issue 2, 2010, Pages 129-
|
Irreversible blindness secondary to posterior reversible encephalopathy syndrome following CHOP combination chemotherapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
GLUCOSE;
PREDNISOLONE;
PROTEIN;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
VAP CYCLO PROTOCOL;
VAP-CYCLO PROTOCOL;
ADULT;
ARTICLE;
BLINDNESS;
BLURRED VISION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CASE REPORT;
CEREBROSPINAL FLUID ANALYSIS;
DISEASE ASSOCIATION;
DISEASE COURSE;
EYE EXAMINATION;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
IRREVERSIBLE BLINDNESS;
MULTIPLE CYCLE TREATMENT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PERIPHERAL T CELL LYMPHOMA;
POLYMERASE CHAIN REACTION;
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
VISUAL ACUITY;
CHEMICALLY INDUCED DISORDER;
MIDDLE AGED;
TOXICITY AND INTOXICATION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLINDNESS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
HUMANS;
LYMPHOMA, T-CELL, PERIPHERAL;
MAGNETIC RESONANCE IMAGING;
MIDDLE AGED;
NEUROTOXICITY SYNDROMES;
PREDNISOLONE;
VINCRISTINE;
|
EID: 77954344531
PISSN: 00071048
EISSN: 13652141
Source Type: Journal
DOI: 10.1111/j.1365-2141.2010.08189.x Document Type: Article |
Times cited : (7)
|
References (1)
|